{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:59:33Z","timestamp":1780984773957,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guizhou Provincial Clinical Special Project","award":["Qian Ke He Cheng Guo-LC[2026] General 299"],"award-info":[{"award-number":["Qian Ke He Cheng Guo-LC[2026] General 299"]}]},{"name":"The Internal Grant of Beijing Jishuitan Hospital","award":["No. 3-1-992-921-13"],"award-info":[{"award-number":["No. 3-1-992-921-13"]}]},{"name":"Beijing Jishuitan Hospital Research Funding","award":["No. ZR-202517"],"award-info":[{"award-number":["No. ZR-202517"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10067-026-08088-w","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:52:47Z","timestamp":1774792367000},"page":"3705-3712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term efficacy of iguratimod in treating knee osteoarthritis: a 12-month retrospective study"],"prefix":"10.1007","volume":"45","author":[{"given":"Xueya","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7206-7632","authenticated-orcid":false,"given":"Xiaoli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"key":"8088_CR1","doi-asserted-by":"publisher","unstructured":"(2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 392:1789\u20131858. https:\/\/doi.org\/10.1016\/S0140-6736(18)32279-7","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"8088_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrrheum.2014.44","volume":"10","author":"DJ Hunter","year":"2014","unstructured":"Hunter DJ, Schofield D, Callander E (2014) The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol 10:437\u2013441. https:\/\/doi.org\/10.1038\/nrrheum.2014.44","journal-title":"Nat Rev Rheumatol"},{"key":"8088_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMcp1903768","volume":"384","author":"L Sharma","year":"2021","unstructured":"Sharma L (2021) Osteoarthritis of the knee. N Engl J Med 384:51\u201359. https:\/\/doi.org\/10.1056\/NEJMcp1903768","journal-title":"N Engl J Med"},{"key":"8088_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","volume":"104","author":"B Abramoff","year":"2020","unstructured":"Abramoff B, Caldera FE (2020) Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin North Am 104:293\u2013311. https:\/\/doi.org\/10.1016\/j.mcna.2019.10.007","journal-title":"Med Clin North Am"},{"key":"8088_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","volume":"16","author":"W Zhang","year":"2008","unstructured":"Zhang W, Moskowitz RW, Nuki G et al (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil 16:137\u2013162. https:\/\/doi.org\/10.1016\/j.joca.2007.12.013","journal-title":"Osteoarthr Cartil"},{"key":"8088_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-019-0067-6","volume":"7","author":"J Li","year":"2019","unstructured":"Li J, Bao J, Zeng J et al (2019) Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology. Bone Res 7:27. https:\/\/doi.org\/10.1038\/s41413-019-0067-6","journal-title":"Bone Res"},{"key":"8088_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1248\/bpb1978.15.649","volume":"15","author":"K Tanaka","year":"1992","unstructured":"Tanaka K, Aikawa Y, Kawasaki H et al (1992) Pharmacological studies on 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a novel antiinflammatory agent. 4th communication\u202f: inhibitory effect on the production of interleukin-1 and interleukin-6. J Pharmacobiodyn 15:649\u2013655. https:\/\/doi.org\/10.1248\/bpb1978.15.649","journal-title":"J Pharmacobiodyn"},{"key":"8088_CR8","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.4049\/jimmunol.1300832","volume":"191","author":"Q Luo","year":"2013","unstructured":"Luo Q, Sun Y, Liu W et al (2013) A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide. J Immunol 191:4969\u20134978. https:\/\/doi.org\/10.4049\/jimmunol.1300832","journal-title":"J Immunol"},{"key":"8088_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.intimp.2012.03.003","volume":"13","author":"F Du","year":"2012","unstructured":"Du F, L\u00fc LJ, Teng JL et al (2012) T-614 alters the production of matrix metalloproteinases (MMP-1 and MP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro. Int Immunopharmacol 13:54\u201360. https:\/\/doi.org\/10.1016\/j.intimp.2012.03.003","journal-title":"Int Immunopharmacol"},{"key":"8088_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13018-021-02530-2","volume":"16","author":"S Cong","year":"2021","unstructured":"Cong S, Meng Y, Wang L et al (2021) T-614 attenuates knee osteoarthritis via regulating Wnt\/\u03b2-catenin signaling pathway. J Orthop Surg Res 16:1\u201310. https:\/\/doi.org\/10.1186\/s13018-021-02530-2","journal-title":"J Orthop Surg Res"},{"key":"8088_CR11","doi-asserted-by":"crossref","unstructured":"Sun Y, Ye D, Zhang P et al (2016) Anti-rheumatic drug iguratimod (T-614) alleviates cancer-induced bone destruction via down-regulating interleukin-6 production in a nuclear factor-\u03baB-dependent manner. J Huazhong Univ Sci Technol Med Sci 36:691\u2013699","DOI":"10.1007\/s11596-016-1646-z"},{"key":"8088_CR12","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s10067-020-04986-9","volume":"39","author":"S Shrestha","year":"2020","unstructured":"Shrestha S, Zhao J, Yang C, Zhang J (2020) Relative efficacy and safety of iguratimod monotherapy for the treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 39:2139\u20132150. https:\/\/doi.org\/10.1007\/s10067-020-04986-9","journal-title":"Clin Rheumatol"},{"key":"8088_CR13","doi-asserted-by":"publisher","unstructured":"Long Z, Zeng L, He Q et al (2023) Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases. Front Immunol 14:1150661. https:\/\/doi.org\/10.3389\/fimmu.2023.1150661","DOI":"10.3389\/fimmu.2023.1150661"},{"key":"8088_CR14","doi-asserted-by":"publisher","unstructured":"Mu R, Li C, Li X et al (2021) Effectiveness and safety of iguratimod treatment in patients with active rheumatoid arthritis in Chinese: a nationwide, prospective real-world study. Lancet Reg Health West Pacific. https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100128","DOI":"10.1016\/j.lanwpc.2021.100128"},{"key":"8088_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2024.1440584","volume":"28","author":"Z Long","year":"2024","unstructured":"Long Z, Zeng L, Yang K (2024) A systematic review and meta-analysis of the ef fi cacy and safety of iguratimod in the treatment of in flammatory arthritis and degenerative arthritis. Front Pharmacol 28:1\u201320. https:\/\/doi.org\/10.3389\/fphar.2024.1440584","journal-title":"Front Pharmacol"},{"key":"8088_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1117713","author":"W Xu","year":"2023","unstructured":"Xu W, Wang X, Liu D et al (2023) Identification and validation of hub genes and potential drugs involved in osteoarthritis through bioinformatics analysis. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2023.1117713","journal-title":"Front Genet"},{"key":"8088_CR17","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780290816","volume":"29","author":"R Altman","year":"1986","unstructured":"Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 29:1039\u20131049. https:\/\/doi.org\/10.1002\/art.1780290816","journal-title":"Arthritis Rheum"},{"key":"8088_CR18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JH Kellgren","year":"1957","unstructured":"Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494\u2013502","journal-title":"Ann Rheum Dis"},{"key":"8088_CR19","doi-asserted-by":"publisher","unstructured":"Camacho PM, Petak SM (2020) Clinical Practice Guidelines American Association Of Clinical Endocrinologists\/American College Of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142020 Update. 26:1\u201346. https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL","DOI":"10.4158\/GL-2020-0524SUPPL"},{"key":"8088_CR20","doi-asserted-by":"publisher","unstructured":"Roemer FW, Collins J, Kwoh CK et al (2020) MRI-based screening for structural definition of eligibility in clinical DMOAD trials: rapid osteoarthritis MRI eligibility score (ROAMES). Osteoarthr Cartil 28:71\u201381. https:\/\/doi.org\/10.1016\/j.joca.2019.08.005","DOI":"10.1016\/j.joca.2019.08.005"},{"key":"8088_CR21","doi-asserted-by":"publisher","unstructured":"Carlsson AM (1983) Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16(1):87\u2013101. https:\/\/doi.org\/10.1016\/0304-3959(83)90088-X","DOI":"10.1016\/0304-3959(83)90088-X"},{"key":"8088_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1151-6","volume":"18","author":"E Nikiphorou","year":"2016","unstructured":"Nikiphorou E, Radner H, Chatzidionysiou K et al (2016) Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature. Arthritis Res Ther 18:251. https:\/\/doi.org\/10.1186\/s13075-016-1151-6","journal-title":"Arthritis Res Ther"},{"key":"8088_CR23","first-page":"95","volume":"1","author":"N Bellamy","year":"1988","unstructured":"Bellamy N, Buchanan WW, Goldsmith CH et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient-relevant outcomes following total hip or knee arthroplasty. J Orthop Rheumatol 1:95\u2013108","journal-title":"J Orthop Rheumatol"},{"key":"8088_CR24","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/art.34453","volume":"64","author":"RF Loeser","year":"2012","unstructured":"Loeser RF, Goldring SR, Scanzello CR, Goldring MB (2012) Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 64:1697\u20131707. https:\/\/doi.org\/10.1002\/art.34453","journal-title":"Arthritis Rheum"},{"key":"8088_CR25","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.joca.2014.05.025","volume":"22","author":"M Hall","year":"2014","unstructured":"Hall M, Doherty S, Courtney P et al (2014) Synovial pathology detected on ultrasound correlates with the severity of radiographic knee osteoarthritis more than with symptoms. Osteoarthr Cartil 22:1627\u20131633. https:\/\/doi.org\/10.1016\/j.joca.2014.05.025","journal-title":"Osteoarthr Cartil"},{"key":"8088_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/rheumatology\/key305","volume":"58","author":"JE Davis","year":"2019","unstructured":"Davis JE, Ward RJ, MacKay JW et al (2019) Effusion-synovitis and infrapatellar fat pad signal intensity alteration differentiate accelerated knee osteoarthritis. Rheumatology Oxford 58:418\u2013426. https:\/\/doi.org\/10.1093\/rheumatology\/key305","journal-title":"Rheumatology Oxford"},{"key":"8088_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69328-w","volume":"10","author":"K Ishibashi","year":"2020","unstructured":"Ishibashi K, Sasaki E, Ota S et al (2020) Detection of synovitis in early knee osteoarthritis by MRI and serum biomarkers in Japanese general population. Sci Rep 10:12310. https:\/\/doi.org\/10.1038\/s41598-020-69328-w","journal-title":"Sci Rep"},{"key":"8088_CR28","doi-asserted-by":"crossref","unstructured":"Kim H, Seo J, Lee Y et al (2022) The current state of the osteoarthritis drug development pipeline: comprehensive narrative review of the present challenges and future opportunities. Ther Adv Musculoskelet Dis 14:1759720X221085952","DOI":"10.1177\/1759720X221085952"},{"key":"8088_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-021-02530-2","volume":"16","author":"S Cong","year":"2021","unstructured":"Cong S, Meng Y, Wang L et al (2021) T-614 attenuates knee osteoarthritis via regulating Wnt\/\u03b2-catenin signaling pathway. J Orthop Surg Res 16:403. https:\/\/doi.org\/10.1186\/s13018-021-02530-2","journal-title":"J Orthop Surg Res"},{"key":"8088_CR30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/art.24643","volume":"61","author":"L-J Lu","year":"2009","unstructured":"Lu L-J, Bao C, Dai M et al (2009) Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate. Arthritis Rheum 61:979\u2013987. https:\/\/doi.org\/10.1002\/art.24643","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08088-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08088-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08088-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:24:41Z","timestamp":1780982681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08088-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8088"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08088-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study complied with the Declaration of Helsinki and was approved by the Ethics\u00a0Committee of Beijing Jishuitan Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}